Abstracts
Abstract
In light of high-profile cases of sexual assault and other unethical conduct by therapists, recent clinical research involving psychedelic drugs has generally mandated the video recording of therapy sessions. In this paper, I address a gap in the literature by investigating ethical issues related to video recording in the unique context of psychedelic therapy sessions. I begin by summarizing the important benefits and risks related to video recording. I then examine ethical concerns about mandatory recording of psychedelic therapy sessions from a patient perspective and argue that these concerns must be taken seriously by clinicians and researchers. I also examine the view that video recording is essential for clinician safety. Given the legitimacy of concerns from both perspectives, I outline some basic informed consent considerations that could generate dialogue around potential patient concerns and defend the option to opt-out for both patients and clinicians. In conclusion, I underscore the importance of further critical bioethical inquiry and qualitative research regarding video recording practices in the context of psychedelic-assisted therapies.
Keywords:
- psychedelic therapy,
- bioethics of technology,
- video recording,
- MDMA,
- philosophy of psychiatry
Résumé
Après des cas très médiatisés d’agressions sexuelles et d’autres comportements contraires à l’éthique de la part de thérapeutes, la recherche clinique récente sur les drogues psychédéliques a généralement rendu obligatoire l’enregistrement vidéo de toutes les séances de thérapie. Dans cet article, j’examine les questions éthiques liées à l’enregistrement vidéo dans le contexte unique des séances de thérapie psychédélique. Je commence par résumer les avantages et les risques importants liés à l’enregistrement vidéo, puis ensuite les préoccupations éthiques concernant l’enregistrement obligatoire des séances de thérapie psychédélique du point de vue du patient, et je soutiens que ces préoccupations doivent être prises au sérieux par les cliniciens et chercheurs. J’examine également le point de vue selon lequel l’enregistrement vidéo est essentiel pour la sécurité des cliniciens. Acceptant la légitimité des préoccupations des deux points de vue, j’expose quelques considérations de base sur le consentement éclairé qui pourraient générer un dialogue autour des préoccupations potentielles des patients. Je défends l’option de refuser, tant pour les patients que pour les cliniciens. En conclusion, je souligne l’importance de poursuivre l’enquête bioéthique critique et la recherche qualitative concernant les pratiques d’enregistrement vidéo dans le contexte des thérapies assistées par les psychédéliques.
Mots-clés :
- thérapie psychédélique,
- bioéthique des technologies,
- enregistrement vidéo,
- MDMA,
- philosophie de la psychiatrie
Appendices
Bibliography
- 1. Goldhill O. Psychedelic therapy has a sexual abuse problem. Quartz. 3 Mar 2020.
- 2. Rosin H. You won’t feel high after watching this video. The Cut. 22 Mar 2022.
- 3. Funkenstein AB, Kessler KA, Schen CR. Learning through the lens: ethical considerations in videotaping psychotherapy. Harv Rev Psychiatry. 2014;22(5):316-22.
- 4. Carlin SC, Scheld S. MAPS MDMA-Assisted Therapy Code of Ethics. MAPS Bulletin. 2019;29(1)24-27.
- 5. Brennan W, Jackson MA, MacLean K, Ponterotto JG. A qualitative exploration of relational ethical challenges and practices in psychedelic healing. J Humanist Psychol. 2021;00221678211045265.
- 6. Douglas SL, McRae A, Calder L, et al. Ethical, legal and administrative implications of the use of video and audio recording in an emergency department in Ontario, Canada. BMJ Innov. 2021;7(1):224-30.
- 7. Falzone RL, Hall S, Beresin E V. How and why for the camera-shy: using digital video in psychiatry. Child Adolesc Psychiatr Clin N Am. 2005;14(3):603-12.
- 8. Clare SC. Clinical supervision in MDMA therapy training: an ethical commitment. MAPS Bulletin. 2018;28(1):25-26.
- 9. Alder S. HIPAA violation and data breach results in 4.8m fine. The HIPAA Journal. 6 May 2014.
- 10. Ornstein C. Hospital to punish snooping on Spears. Los Angeles Times. 15 Mar 2008.
- 11. Hutchby I, O’Reilly M, Parker N. Ethics in praxis: Negotiating the presence and functions of a video camera in family therapy. Discourse Stud. 2012;14(6):675-90.
- 12. Lee A. Videotape recording of clinical encounters. Infant Observation. 2007;10(1):87-8.
- 13. Briggie A, Hilsenroth M, Conway F, Muran J, Jackson J. Patient comfort with audio or video recording of their psychotherapy sessions: Relation to symptomatology, treatment refusal, duration, and outcome. Prof Psychol Res Pr. 2016;47(1):66-76.
- 14. Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ. Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology. 2022;36(3):258-72.
- 15. Carhart-Harris R. Psychedelic drugs, magical thinking, and psychosis. J Neurology, Neurosurgery & Psychiatry. 2013;84(9):e1.
- 16. Hartogsohn I. Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. J Psychopharmacology. 2016;30(12):1259-67.
- 17. Noorani T. Containment matters: set and setting in contemporary psychedelic psychiatry. Philosophy, Psychiatry, & Psychology. 2021;28(3):201-16.
- 18. Winkelman M. Shamanic guidelines for psychedelic medicine. In: Winkelman M, Roberts T, editors. Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments. Westport, CT: Praeger/Greenwood Publishers; 2007. p. 143-67.
- 19. Labate BC, Cavnar C. Ayahuasca Shamanism in the Amazon and Beyond. Oxford: Oxford University Press; 2014.
- 20. Lifshitz M, Sheiner E, Kirmayer LJ. Cultural neurophenomenology of psychedelic thought: guiding the “unconstrained” mind through ritual context. In: Christoff K, Fox KCR, editors. The Oxford Handbook of Spontaneous Thought: Mind-Wandering, Creativity, and Dreaming. Oxford University Press; 2018. p. 573-94.
- 21. Pope KS, Vetter VA. Prior therapist-patient sexual involvement among patients seen by psychologists. Psychotherapy: Theory, Research, Practice, Training. 1991;28(3):429-38.
- 22. Villeneuve N, Prescott D. Examining the dark sides of psychedelic therapy. ATSA Forum Newsletter. 2022;34(3):1-12.
- 23. Smith WR, Sisti D. Ethics and ego dissolution: the case of psilocybin. J Med Ethics. 2021;47(12):807-14.
- 24. Michaels TI, Purdon J, Collins A, Williams MT. Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature. BMC Psychiatry. 2018;18:245.